Welcome, Guest. Please login or register.
April 20, 2024, 05:54:46 am

Login with username, password and session length

  • Total Members: 6307
  • Latest: golfer
  • Total Posts: 55126
  • Total Topics: 4851
  • Online Today: 85
  • Online Ever: 1314
  • (June 22, 2016, 05:23:42 am)
Users Online
Users: 0
Guests: 72
Total: 72


Welcome to the Hep Forums, a round-the-clock discussion area for people who have Fatty Liver Disease, Hepatitis B, C or a co-infection, their friends and family and others with questions about hepatitis and liver health. Check in frequently to read what others have to say, post your comments, and hopefully learn more about how you can reach your own health goals.

Privacy Warning: Please realize that these forums are open to all, and are fully searchable via Google and other search engines. If this concerns you, then do not use a username or avatar that are self-identifying in any way. We do not allow the deletion of anything you post in these forums, so think before you post.
  • The information shared in these forums, by moderators and members, is designed to complement, not replace, the relationship between an individual and his/her own physician.
  • All members of these forums are, by default, not considered to be licensed medical providers. If otherwise, users must clearly define themselves as such.
  • Product advertisement (including links); banners; and clinical trial, study or survey participation—is strictly prohibited by forums members unless permission has been secured from the Hep Forum Moderators.
Finished Reading This? You can collapse this or any other box on this page by clicking the symbol in each box.

Author Topic: Curing Hepatitis C Lowers the Risk of Premature Death  (Read 5083 times)

0 Members and 1 Guest are viewing this topic.

Offline Hep Editors

  • Member
  • Posts: 784
    • Hep Mag
Curing Hepatitis C Lowers the Risk of Premature Death
« on: February 13, 2018, 10:22:26 am »
Among people without liver disease, curing hepatitis C virus (HCV) with interferon-free drug regimens is associated with a reduced risk of death, Healio reports.

Publishing their findings in the journal Hepatology, researchers analyzed data from the Veterans Affairs Hepatitis C Clinical Case Registry on 103,346 people with genotype 1, 2 or 3 of hep C who had neither HIV nor advanced liver disease. The latter category was defined as having a FIB-4 score (which measures liver disease severity) at or below 3.25 and no diagnosis of cirrhosis, liver decompensation or hepatocellular carcinoma (HCC, the most common form of liver cancer), or history of liver transplantation.



© 2024 Smart + Strong. All Rights Reserved.   terms of use and your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.